Zomedica Corp. also files under ZOMDF, TSSI; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Klass Russell Kevin | Sr Vice President, Sales | Grant(A) | 250K | — | $0 |
| Aug 5, 2026 | DeHaan-Fullerton Karen | General Counsel | Grant(A) | 250K | — | $0 |
| Aug 5, 2026 | Blair Anthony K | COO | Grant(A) | 500K | — | $0 |
| Nov 17, 2025 | Nichols Pamela | Director | Grant(A) | 1.8M | — | $0 |
| Nov 17, 2025 | Williams Rodney James | Director | Grant(A) | 2.0M | — | $0 |
| Nov 17, 2025 | Powers Johnny D | Director | Grant(A) | 1.8M | — | $0 |
| Nov 17, 2025 | Rowe Jeffrey M | Director | Grant(A) | 2.1M | — | $0 |
| Nov 17, 2025 | Macleod Christopher Ross | Director | Grant(A) | 1.8M | — | $0 |
| Nov 17, 2025 | Whelan Sean | Director | Grant(A) | 2.0M | — | $0 |
| Nov 17, 2025 | Cohen Robert | Director | Grant(A) | 1.8M | — | $0 |
| Nov 13, 2025 | Klass Russell Kevin | Sr Vice President, Sales | Buy(P) | 150K | $0.10 | $15K |
| Nov 10, 2025 | Klass Russell Kevin | Sr Vice President, Sales | Buy(P) | 120K | $0.10 | $12K |
| Nov 7, 2025 | Klass Russell Kevin | Sr Vice President, Sales | Buy(P) | 5K | $0.10 | $500 |
| Nov 6, 2025 | Klass Russell Kevin | Sr Vice President, Sales | Buy(P) | 253K | $0.08 | $20K |
| Aug 12, 2025 | Klass Russell Kevin | Sr Vice President, Sales | Buy(P) | 250K | $0.04 | $10K |
| Aug 12, 2025 | Klass Russell Kevin | Sr Vice President, Sales | Buy(P) | 745K | $0.04 | $30K |
| Aug 11, 2025 | Klass Russell Kevin | Sr Vice President of Sales | Buy(P) | 250K | $0.04 | $10K |
| Aug 11, 2025 | Klass Russell Kevin | Sr Vice President, Sales | Buy(P) | 61K | $0.04 | $2K |
| Aug 11, 2025 | Klass Russell Kevin | Sr Vice President of Sales | Buy(P) | 250K | $0.04 | $10K |
| Aug 8, 2025 | Klass Russell Kevin | Sr Vice President of Sales | Buy(P) | 500K | $0.04 | $20K |
| Jun 12, 2025 | Blair Anthony K | COO | Grant(A) | 750K | — | $0 |
| Jun 12, 2025 | Klass Russell Kevin | Sr Vice President of Sales | Grant(A) | 500K | — | $0 |
| Jun 12, 2025 | Heaton Larry C II | CEO, Director | Grant(A) | 4.0M | — | $0 |
| Jun 12, 2025 | DeHaan-Fullerton Karen | General Counsel | Grant(A) | 500K | — | $0 |
| May 21, 2025 | Blair Anthony K | COO | Buy(P) | 36K | $0.05 | $2K |
| May 21, 2025 | Blair Anthony K | COO | Buy(P) | 64K | $0.05 | $3K |
| May 19, 2025 | Powers Johnny D | Director | Buy(P) | 500K | $0.05 | $25K |
| May 19, 2025 | DeHaan-Fullerton Karen | General Counsel/Corporate Secy | Buy(P) | 104K | $0.05 | $5K |
| Mar 17, 2025 | Blair Anthony K | COO | Buy(P) | 500K | $0.06 | $30K |
| Mar 17, 2025 | Klass Russell Kevin | Sr Vice President of Sales | Buy(P) | 700K | $0.07 | $49K |
| Mar 17, 2025 | Williams Rodney James | Director | Buy(P) | 100K | $0.07 | $7K |
| Mar 17, 2025 | Heaton Larry C II | CEO, Director | Buy(P) | 10K | $0.05 | $500 |
| Mar 17, 2025 | Rowe Jeffrey M | Director | Buy(P) | 101K | $0.07 | $7K |
| Mar 17, 2025 | Rowe Jeffrey M | Director | Buy(P) | 500K | $0.06 | $30K |
| Mar 17, 2025 | Rowe Jeffrey M | Director | Buy(P) | 4K | $0.07 | $299 |
| Mar 17, 2025 | Rowe Jeffrey M | Director | Buy(P) | 35K | $0.07 | $2K |
| Mar 17, 2025 | Rowe Jeffrey M | Director | Buy(P) | 68K | $0.07 | $5K |
| Mar 17, 2025 | Jordan Scott | Chief Financial Officer | Buy(P) | 300K | $0.06 | $18K |
| Mar 17, 2025 | Powers Johnny D | Director | Buy(P) | 100K | $0.07 | $7K |
| Mar 17, 2025 | Macleod Christopher Ross | Director | Buy(P) | 143K | $0.06 | $9K |
| Mar 17, 2025 | Powers Johnny D | Director | Buy(P) | 50K | $0.07 | $4K |
| Mar 17, 2025 | Williams Rodney James | Director | Buy(P) | 100K | $0.07 | $7K |
| Mar 17, 2025 | Powers Johnny D | Director | Buy(P) | 100K | $0.07 | $7K |
| Mar 17, 2025 | Powers Johnny D | Director | Buy(P) | 100K | $0.07 | $7K |
| Mar 17, 2025 | Powers Johnny D | Director | Buy(P) | 50K | $0.07 | $4K |
| Mar 17, 2025 | Rowe Jeffrey M | Director | Buy(P) | 731K | $0.07 | $51K |
| Mar 17, 2025 | Powers Johnny D | Director | Buy(P) | 100K | $0.07 | $7K |
| Mar 17, 2025 | Heaton Larry C II | CEO, Director | Buy(P) | 192K | $0.06 | $12K |
| Mar 17, 2025 | Heaton Larry C II | CEO, Director | Buy(P) | 179K | $0.06 | $11K |
| Mar 17, 2025 | Heaton Larry C II | CEO, Director | Buy(P) | 119K | $0.06 | $7K |
| Feb 21, 2025 | Klass Russell Kevin | Sr Vice President of Sales | Grant(A) | 200K | — | $0 |
| Jan 1, 2025 | Jordan Scott | Chief Financial Officer | Grant(A) | 5.0M | — | $0 |
| Nov 11, 2024 | Whelan Sean | Director | Grant(A) | 2.0M | — | $0 |
| Nov 11, 2024 | Rowe Jeffrey M | Director | Grant(A) | 2.1M | — | $0 |
| Nov 11, 2024 | Powers Johnny D | Director | Grant(A) | 1.8M | — | $0 |
| Nov 11, 2024 | Nichols Pamela | Director | Grant(A) | 2.0M | — | $0 |
| Nov 11, 2024 | Macleod Christopher Ross | Director | Grant(A) | 1.8M | — | $0 |
| Nov 11, 2024 | Cohen Robert | Director | Grant(A) | 1.8M | — | $0 |
| Nov 11, 2024 | DeHaan-Fullerton Karen | General Counsel/Corporate Secy | Grant(A) | 500K | — | $0 |
| Nov 11, 2024 | Blair Anthony K | COO | Grant(A) | 400K | — | $0 |
| Nov 11, 2024 | Powers Johnny D | Director | Buy(P) | 100K | $0.12 | $12K |
| Nov 11, 2024 | Powers Johnny D | Director | Grant(A) | 2.0M | — | $0 |
| Nov 11, 2024 | Heaton Larry C II | CEO, Director | Buy(P) | 100K | $0.12 | $12K |
| Nov 11, 2024 | Klass Russell Kevin | Vice President of Sales | Buy(P) | 290K | $0.12 | $35K |
| Nov 11, 2024 | Klass Russell Kevin | Vice President of Sales | Buy(P) | 210K | $0.12 | $25K |
| Nov 10, 2024 | Williams Rodney James | Director | Grant(A) | 2.0M | — | $0 |
| Nov 8, 2024 | Blair Anthony K | COO | Buy(P) | 150K | $0.12 | $18K |
| Sep 5, 2024 | Heaton Larry C II | CEO, Director | Buy(P) | 100K | $0.13 | $13K |
| Aug 28, 2024 | Powers Johnny D | Director | Buy(P) | 100K | $0.13 | $13K |
| Aug 20, 2024 | Blair Anthony K | COO | Buy(P) | 100K | $0.14 | $14K |
| Jun 12, 2024 | Klass Russell Kevin | Vice President of Sales | Buy(P) | 300K | $0.16 | $48K |
| Jun 11, 2024 | Klass Russell Kevin | Vice President of Sales | Buy(P) | 500K | $0.15 | $75K |
| Jun 10, 2024 | Klass Russell Kevin | Vice President of Sales | Buy(P) | 200K | $0.15 | $30K |
| Jun 10, 2024 | Donato Peter | Chief Financial Officer | Buy(P) | 25K | $0.15 | $4K |
| May 17, 2024 | Powers Johnny D | Director | Buy(P) | 50K | $0.17 | $9K |
| May 17, 2024 | Powers Johnny D | Director | Buy(P) | 50K | $0.18 | $9K |
| May 16, 2024 | Powers Johnny D | Director | Buy(P) | 25K | $0.18 | $5K |
| May 14, 2024 | Powers Johnny D | Director | Buy(P) | 31K | $0.14 | $4K |
| May 14, 2024 | Powers Johnny D | Director | Buy(P) | 19K | $0.14 | $3K |
| May 13, 2024 | Heaton Larry C II | CEO | Buy(P) | 100K | $0.14 | $14K |
| May 13, 2024 | Blair Anthony K | COO | Buy(P) | 150K | $0.14 | $21K |
| May 13, 2024 | Donato Peter | Chief Financial Officer | Grant(A) | 2.5M | — | $0 |
| May 13, 2024 | Powers Johnny D | Director | Buy(P) | 100K | $0.14 | $14K |
| Dec 15, 2023 | Powers Johnny D | Director | Buy(P) | 100K | $0.17 | $17K |
| Nov 17, 2023 | Powers Johnny D | Director | Buy(P) | 100K | $0.17 | $17K |
| Nov 17, 2023 | Heaton Larry C II | CEO | Buy(P) | 100K | $0.17 | $17K |
| Nov 15, 2023 | Powers Johnny D | Director | Buy(P) | 150K | $0.17 | $26K |
| Nov 7, 2023 | Klass Russell Kevin | Vice President of Sales | Grant(A) | 2.0M | — | $0 |
| Nov 7, 2023 | Klass Russell Kevin | Vice President of Sales | Grant(A) | 2.0M | — | $0 |
| May 26, 2023 | Heaton Larry C II | CEO | Buy(P) | 100K | $0.19 | $19K |
| May 25, 2023 | Powers Johnny D | Director | Buy(P) | 100K | $0.19 | $19K |
| Mar 16, 2023 | Donato Peter | Chief Financial Officer | Grant(A) | 5.0M | — | $0 |
| Dec 9, 2022 | Cohen Robert | Director | Grant(A) | 1.5M | — | $0 |
| Dec 9, 2022 | Powers Johnny D | Director | Grant(A) | 1.5M | — | $0 |
| Dec 9, 2022 | Nichols Pamela | Director | Grant(A) | 231K | — | $0 |
| Dec 9, 2022 | Whelan Sean | Director | Grant(A) | 1.2M | — | $0 |
| Dec 9, 2022 | Rowe Jeffrey M | Director | Grant(A) | 1.5M | — | $0 |
| Dec 9, 2022 | Williams Rodney James | Director | Grant(A) | 1.5M | — | $0 |
| Dec 9, 2022 | Macleod Christopher Ross | Director | Grant(A) | 1.5M | — | $0 |
| Oct 4, 2022 | Heaton Larry C II | CEO | Grant(A) | 4.0M | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Zomedica Corp., SEC CIK 0001684144. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under ZOM and shows every filing by that issuer (also filed as ZOMDF, TSSI).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for ZOM